Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal

Schizophrenia Bulletin

Volumn 22, Issue 4, 1996, Pages 591-595

  Shiovitz, Thomas M ^b   Welke, Timothy L ^b   Tigel, Phillip D ^b   Anand, Ravi ^c   Hartman, Richard D ^c   Sramek, John J ^b   Kurtz, Neil M ^d   Cutler, Neal R ^a,b  

^a California Clinical Trials ^*  (United States)

^b CALIFORNIA CLINICAL TRIALS   (United States)

^c Sandoz Pharma Ltd   (Switzerland)

^d Worldwide Clinical Trials   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; TIOTIXENE; TRIHEXYPHENIDYL;

ACUTE PSYCHOSIS; ADULT; AGITATION; BIOEQUIVALENCE; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REBOUND; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; VOMITING; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 0029958232     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.4.591     Document Type: Review

References (22)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: The Association, 1987.
2. Chouinard, G., and Jones, B.D. Neuroleptic-induced supersensitivity psychosis. American Journal of Psychiatry, 135:1409-1410, 1978.
3. Daniel, D.G.; Goldberg, T.; Weinberger, D.R.; Kleinman, J.E.; Pickar, D.; Williams, T.S.; and Lubick, L.J. "Clozapine Versus Risperidone in Psychosis." Presented at the Annual Meeting of the Society of Biological Psychiatry, Philadelphia, PA, May 1994.
4. Davis, J.M. Maintenance therapy and the natural course of schizophrenia. Journal of Clinical Psychiatry, 11:18-21, 1985.
5. de Leon, J.; Stanilla, J.K.; White, A.O.; and Simpson, G.M. Anticholinergics to treat clozapine withdrawal. [Letter] Journal of Clinical Psychiatry, 55:3, 1994.
6. Dickson, R.; Williams, R.; and Dalby, J.T. Dystonic reaction and relapse with clozapine discontinuation and risperidone initiation. [Letter] Canadian Journal of Psychiatry, 39:184, 1994.
7. Dilsaver, S.C. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena. Progress in Neuropsychopharmacology and Biological Psychiatry, 14:137-161, 1990.
8. Dilsaver, S.C.; Feinberg, M.; and Greden, J.F. Antidepressant withdrawal symptoms treated with anticholinergic agents. American Journal of Psychiatry, 140:249-251, 1983.
9. Ekblom, B.; Eriksson, K.; and Lindström, L.H. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology, 83:293-294, 1984.
10. Eklund, K. Supersensitivity and clozapine withdrawal. [Letter] Psychopharmacology, 91:135, 1987.
11. 11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET). Psychopharmacology, 89:248-252, 1986.
12. Kay, S.R.; Fiszbein, A.; and Opler, L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2):261-276, 1987.
13. Lieberman, J.A.; Kane, J.M.; and Johns, C.A. Clozapine: Guidelines for clinical management. Journal of Clinical Psychiatry, 50:329-338, 1989.
14. National Institute of Mental Health. Reports of clozapine-withdrawal side effects prompt response. Psychiatric News, October 21, 1994, p. 10.
15. Oberholzer, A.F.; Hendriksen, C.; Monsch, A.U.; Heierli, B.; and Stähelin, H.B. Safety and effectiveness of low-dose clozapine in psychogeriatric patients: A preliminary study. International Psychogeriatrics, 4:187-195, 1992.
16. Parsa, M.A.; Al-Lahham, Y.H.; Ramirez, L.F.; and Meltzer, H.Y. Prolonged psychotic relapse after abrupt clozapine withdrawal. [Letter] Journal of Clinical Psychopharmacology, 13:154-155, 1993.
17. Perenyi, A.; Kuncz, E.; and Bagdy, G. Early relapse after sudden withdrawal or dose reduction of clozapine. [Letter] Psychopharmacology, 86:244, 1985.
18. Pickar, D. Serotonin and dopamine abnormalities in schizophrenia. Journal of Clinical Psychiatry Monograph, 12(2):10-12, 1994.
19. Pollack, S. Despite widespread use, optimal dose of clozapine still undecided. Clinical Psychiatry News, August 1994, p. 21.
20. Simpson, G.M., and Varga, E. Clozapine: A new antipsychotic agent. Current Therapeutic Research, 16:679-686, 1974.
21. Sramek, J.J.; Gaurano, V.; Herrera, J.M.; and Potkin, S.G. Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: Evidence for development of drug tolerance. DICP, Annals of Pharmacotherapy, 24:7-10, 1990.
22. Ungerstedt, U., and Ljungberg, T. Behavioral patterns related to dopamine neurotransmission: Effect of acute and chronic antipsychotic drugs. In: Costa, E., and Gessa, G.L., eds. Advances in Biochemical Psychopharmacology, Vol. 16. New York, NY: Raven Press, 1977. pp. 193-199.